Anthracycline-based adjuvant chemotherapy in breast cancer

被引：1
|
作者：
Gray, Richard [1 ]
机构：
[1] Univ Birmingham, Coll Med Sci, Robert Aitken Inst, Univ Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England
来源：
LANCET | 2010年 / 375卷 / 9729期
基金：
英国医学研究理事会;
关键词：
END-POINTS; TRIALS;
D O I：
10.1016/S0140-6736(10)60867-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1870 / 1871
页数：2
相关论文
共 50 条
  • [1] Concomitant radiotherapy, and anthracycline-based chemotherapy in adjuvant breast cancer treatment
    Ivaldi, G. B.
    Leonardi, M.
    Ferrari, A.
    Morra, A.
    Fossa, B. Jereczek
    Vavassori, A.
    Santoro, L.
    Orecchia, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S180 - S181
  • [2] Effective Antiemetic Therapy Is Important With Adjuvant Anthracycline-based Chemotherapy in Breast Cancer
    Takala, Laura
    Barlund, Maarit
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Pirkko, Liisa
    ANTICANCER RESEARCH, 2019, 39 (01) : 279 - 283
  • [3] Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancer
    Andre, F
    Khalil, A
    Slimane, K
    Massard, C
    Mathieu, MC
    Vignot, S
    Assi, H
    Delaloge, S
    Spielmann, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) : 2996 - 3000
  • [4] Adjuvant anthracycline-based chemotherapy for early breast cancer: do the dose and schedule matter?
    Mano, MS
    Awada, A
    Kerr, J
    Canney, P
    CANCER TREATMENT REVIEWS, 2005, 31 (02) : 69 - 78
  • [5] Optimum anthracycline-based chemotherapy for early breast cancer
    Adlard, Julian W.
    Dodwell, David J.
    LANCET ONCOLOGY, 2001, 2 (08): : 469 - 474
  • [6] Docetaxel and anthracycline-based neoadjuvant chemotherapy in breast cancer
    Tiezzi, D. G.
    Andrade, J. M.
    Macchetti, A. H.
    Clagnan, W. S.
    Marana, H. R.
    Zola, F. E.
    Peria, F. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients
    Chirivella, Isabel
    Bermejo, Begona
    Insa, Amelia
    Perez-Fidalgo, Alejandro
    Magro, Ana
    Rosello, Susana
    Garcia-Garre, Elisa
    Martin, Paloma
    Bosch, Ana
    Lluch, Ana
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 479 - 484
  • [8] Late cardiotoxicity in patients with breast cancer after taxane/anthracycline-based neoadjuvant and adjuvant chemotherapy
    Koroleva, I.
    Kopp, M. V.
    Kasulin, A. N.
    Kucheryavyy, J. A.
    Byakhov, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Cardiac Tolerability of Concurrent Administration of Trastuzumab and Anthracycline-Based Regimen as Adjuvant Chemotherapy for Breast Cancer
    Watanabe, Naoki
    Otsuka, Shoko
    Sasaki, Yoko
    Shimojima, Reiko
    Wani, Yoji
    Uchino, Kaori
    BREAST CARE, 2014, 9 (01) : 46 - 51
  • [10] Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients
    Isabel Chirivella
    Begoña Bermejo
    Amelia Insa
    Alejandro Pérez-Fidalgo
    Ana Magro
    Susana Rosello
    Elisa García-Garre
    Paloma Martín
    Ana Bosch
    Ana Lluch
    Breast Cancer Research and Treatment, 2009, 114 : 479 - 484
12345